Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Robinhood Markets | Milan | Technology | Financial Technology (Fintech) & Infrastructure | 120.3% | €76.06B | 55.3x | 0.05 | €85.56 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Milan | Technology | Financial Technology (Fintech) & Infrastructure | 118.8% | €85.32B | 65.7x | 13.37 | €336.85 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Xetra | Technology | Financial Technology (Fintech) & Infrastructure | 118.6% | €85.32B | 65.7x | 13.37 | €337.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Vienna | Technology | Financial Technology (Fintech) & Infrastructure | 118.4% | €85.32B | 65.7x | 13.37 | €336.75 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D Wave Quantum | Milan | 102% | €3.28B | -27.2x | 2.54 | €13.67 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AST SpaceMobile | Milan | 91.5% | €14.93B | -28.3x | 0.42 | €42.40 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ProQR Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | 91% | €215.66M | -6.2x | 4.42 | €2.09 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 80% | €44.24M | -4.9x | 0.09 | €0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Vienna | Healthcare | Biotechnology & Medical Research | 61.9% | €1.05B | 5.8x | 0.03 | €4.66 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Milan | Healthcare | Biotechnology & Medical Research | 61.8% | €1.05B | 5.8x | 0.04 | €4.66 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Xetra | Healthcare | Biotechnology & Medical Research | 61.6% | €1.05B | 5.8x | 0.04 | €4.64 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curevac | Frankfurt | Healthcare | Biotechnology & Medical Research | 60.4% | €1.05B | 5.8x | 0.04 | €4.68 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ceres Power | Frankfurt | Energy | Renewable Energy | 59.5% | €211.41M | -6.4x | -0.14 | €1.03 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueprint Medicines | Frankfurt | Healthcare | Biotechnology & Medical Research | 52% | €7.22B | -52.7x | -1.12 | €109.35 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Milan | Technology | Software & IT Services | 46.3% | €23.29B | 232x | 2.16 | €126 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Abivax | Frankfurt | Healthcare | Biotechnology & Medical Research | 45.5% | €502.70M | -2.7x | -0.23 | €7.36 | 6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | 38.3% | €502.70M | -2.7x | -0.23 | €7.92 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kinnevik B | BATS Europe | Financials | Investment Holding Companies | 37.1% | €2.38B | -10.1x | -0.15 | €8.33 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philomaxcap | Frankfurt | Technology | Financial Technology (Fintech) & Infrastructure | 36.3% | €176.53M | -5.6x | 0.67 | €1.60 | -13% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Embention Sistemas Inteligentes | Paris | Industrials | Professional & Commercial Services | 32.7% | €155.55M | €26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Cosmo Pharmaceuticals NV | Frankfurt | Healthcare | Pharmaceuticals | 30.5% | €1.07B | 8.1x | 0.01 | €67.50 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | BATS Europe | Healthcare | Pharmaceuticals | 29.8% | €1.07B | 8.1x | 0.01 | €66.67 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosmo Pharmaceuticals NV | Vienna | Healthcare | Pharmaceuticals | 28% | €1.07B | 8.1x | 0.01 | €66.50 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tetragon | Amsterdam | Financials | Collective Investments | 26.8% | €1.20B | 4.2x | €14.64 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Libertas 7 | Madrid | Real Estate | Real Estate Operations | 25.5% | €46.03M | €2.20 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Herald | BATS Europe | Financials | Collective Investments | 25.1% | €1.36B | 9.2x | 0.04 | €27.13 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kinnevik B | Frankfurt | Financials | Investment Holding Companies | 22.3% | €2.34B | -10.1x | -0.15 | €8.24 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dominari | Frankfurt | Financials | Investment Banking & Investment Services | 21.4% | €65.96M | -0.9x | 0.08 | €4.50 | 10.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Baring | BATS Europe | Financials | Collective Investments | 18.8% | €97.67M | 6.7x | 0 | €0.08 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BriQ Properties | Athens | Real Estate | Real Estate Operations | 18.4% | €133.14M | 3.9x | 0.05 | €3 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
JPMorgan EM | BATS Europe | Financials | Collective Investments | 17.9% | €1.38B | 16.8x | 0.06 | €1.37 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | 17.4% | €128.53M | -3.2x | -0.04 | €1.78 | 7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Temple Bar | BATS Europe | Financials | Collective Investments | 17.3% | €1.07B | 6.7x | 0.1 | €3.77 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Capital | Frankfurt | 17.3% | €426.03M | 15.8x | 0.1 | €6.42 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Reinet Invest | Amsterdam | Financials | Investment Banking & Investment Services | 17.3% | €4.58B | 6.1x | 0.11 | €25.80 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fidelity Special | BATS Europe | Financials | Collective Investments | 16.2% | €1.37B | 5.8x | 0 | €4.24 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Schroder Asia Pacific | BATS Europe | Financials | Collective Investments | 16% | €910.62M | 17.1x | 0 | €6.65 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medincell | Paris | Healthcare | Pharmaceuticals | 15.8% | €537.04M | €16.24 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.6% Upside | Upgrade to Pro+ | |||
Pantheon | BATS Europe | Financials | Collective Investments | 15.5% | €1.63B | 16.5x | 0.05 | €3.67 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofina | Vienna | Financials | Investment Holding Companies | 15.4% | €8.90B | 6.6x | 0 | €269.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofina | Brussels | Financials | Investment Holding Companies | 15.4% | €8.90B | 6.6x | 0 | €269.40 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
JPMorgan Asian | BATS Europe | Financials | Collective Investments | 12% | €314.56M | 13.4x | 0.02 | €4.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
F&C Invest | BATS Europe | Financials | Collective Investments | 12% | €6.31B | 5.7x | 0.06 | €13.17 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mercantile | BATS Europe | Financials | Collective Investments | 12% | €2.08B | 8x | 0.03 | €2.89 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
All Iron Re | Madrid | Real Estate | Residential & Commercial REITs | 11% | €189.60M | 15.6x | -0.6 | €12.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blackrock Smaller | BATS Europe | Financials | Collective Investments | 10.7% | €640.90M | -144.4x | -1.5 | €15.16 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
City Of London IT | BATS Europe | Financials | Collective Investments | 10.6% | €2.80B | 11.1x | 0.15 | €5.66 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phoenix Vega Mezz Plc | Athens | Financials | Investment Banking & Investment Services | 9.9% | €85.65M | 1.5x | 0 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merchants | BATS Europe | Financials | Collective Investments | 9.5% | €955.34M | 8x | €6.47 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sofina | BATS Europe | Financials | Investment Holding Companies | 9.4% | €8.90B | 6.6x | 0 | €270.20 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |